News

New research led by Prof Edward Avezov (UK DRI at Cambridge) reveals how the architecture of the cell’s transport network, the endoplasmic reticulum, can go awry and lead to problems with signalling in brain cells in conditions like Alzheimer’s. The study, published in Advanced Science, could lead to new therapeutic...

Dr Daniel Maddison was one of 17 early career researchers honoured by the Alzheimer’s Society this year. He has been awarded a Postdoctoral Fellowship and over the next three years will be working in the Avezov lab at UK Dementia Research Institute at Cambridge with the goal of developing new ways to see and clear toxic...

An international study has found the clearest overview yet on the effects of psychedelics on the human brain. In this article, Professor Emmanuel Stamatakis, lead of the Cognition and Consciousness Imaging Group at the University of Cambridge, explores the findings and why this signals a new phase for psychedelic...

Cambridge scientists have grown miniature circuits in the lab that mimic how the brain and spinal cord connect up, which underlies our movements. They used this model to show how damage to these connections previously considered ‘irreversible’ could, in fact, be reversible. Read the paper: A human corticospinal organoid-...